INTRODUCTION
============

Splenectomy is frequently required in children for various hematologic disorders.^[@B1]^ The first laparoscopic splenectomy (LS) in children was published by Tulman et al^[@B2]^ in 1993. Since that time, many articles have been published regarding this subject, in both adults and children. Despite this, the superiority of LS over open splenectomy (OS) has not been addressed from all its aspects.^[@B3]^

With the optimal acceptance of its clinical advantages, LS emerged as a gold-standard procedure compared with OS. However, it is still controversial and even considered a contraindication for massive splenomegaly.^[@B4]^

In the adult literature, controversy still exists regarding the role of LS in patients with massive splenomegaly.^[@B5]^ LS for massive splenomegaly has generally been found to be associated with a high conversion rate in adults and children. Despite improvements in laparoscopic techniques and the accumulation of laparoscopic experience, concerns have been raised about completing the procedure in pediatric cases with massive splenomegaly.^[@B6]^ The advantages of minimal access surgery in this subgroup of patients with massive splenomegaly are still not clear.^[@B7]^

We aimed to compare the feasibility of LS versus OS for massive splenomegaly from different surgical aspects in children.

METHODS
=======

The data of children aged \<12 years with massive splenomegaly (identified by ultrasonography as splenic size ≥500 mg using the formula described by Downey,^[@B8]^ 0.43 × Length × Width × Thickness = Splenic size \[in grams\]) who underwent splenectomy for hematologic disorders were retrospectively reviewed in 2 pediatric surgery centers from June 2004 until July 2012.

During the period from June 2004 to June 2009, splenectomy for massive splenomegaly was performed by an open technique. From July 2009 onward, all splenectomy procedures for massive splenomegaly were performed laparoscopically (the surgical steps for both procedures were the same in both institutions).

The files of 69 patients who were subjected to splenectomy during the study period were reviewed. Of these patients, 32 were defined as having massive splenomegaly by preoperative ultrasonography: 12 underwent LS and 20 underwent OS.

Using SPSS software, version 17 (IBM, Armonk, New York), we collected and statistically analyzed the following: demographic data, size of the spleen, indications for splenectomy, type of surgical procedure, operative time, intraoperative complications, intraoperative blood loss, conversion to OS, postoperative pain management (pain was evaluated according to the word-graphic rating scale of Tesler et al^[@B9]^), postoperative complications, postoperative time required to start oral feeding, and length of hospital stay.

The χ^2^ test was used to test statistically significant differences in qualitative data, and the *t* test was used to test statistically significant differences in quantitative data. *P*\<.05 was considered to indicate a statistically significant difference.

Surgical Technique for OS
-------------------------

OS was performed through a left subcostal incision. Control of the splenic hilum was achieved with ligation of the splenic artery above the pancreas and then ligation of the splenic vein.

Surgical Technique for LS
-------------------------

For LS, the patient was positioned in the right lateral decubitus position on a neutrally positioned table with the umbilicus at or near the break in the table. The surgeon and the camera operator stood on the patient\'s right side, with the video monitors above and lateral to the patient\'s left shoulder.

The camera port was inserted into the infraumbilical fold, and a 10-mm 30° telescope was used. In cases in which the spleen was extending beyond the midline, the camera port was inserted in the right lumbar area. Three 5-mm trocars were inserted, two in the midline above the umbilicus and one under the lower edge of the spleen in the left iliac fossa.

The splenocolic ligament and the short gastric vessels were divided with a tissue sealing device (Ultracision Harmonic Scalpel; Ethicon Endo-Surgery, Cincinnati, Ohio). The lateral attachments of the spleen were divided completely. The splenic hilum was divided by use of a linear endoscopic vascular stapler device with an articulating end (Endopath ETS Articulating Endocutters; Ethicon Endo-Surgery), and the staple line length was 45 mm in all cases in the study. The device was inserted into the umbilical incision after removal of the 10-mm port and shifting of the 10-mm telescope to a 5-mm 30° telescope in the left lateral port.

An Endobag (Endo Catch II 15 mm Specimen Pouch; Covidien, Mansfield, Massachusetts) was inserted through the umbilicus, and the spleen was moved inside, underwent morcellation, and was extracted. A size 18 Nelaton tube (B. Braun, Melsungen, Germany) was inserted into the bed of the spleen and exited through the left lateral trocar, which was removed within 24 hours. (We insert a drain only in cases of massive splenomegaly.)

RESULTS
=======

There were 22 female and 10 male patients. The age range was 6 to 12 years for the LS group versus 5 to 11 years for the OS group (**[Table 1](#T1){ref-type="table"}**). The indications for splenectomy were hematologic disorders in all cases (sickle cell anemia in 15, chronic idiopathic thrombocytopenic purpura in 6, hereditary spherocytosis in 5, thalassemia major in 4, and autoimmune hemolytic anemia in 2).

###### 

Demographic Data for Both Groups

                        LS Group (12 Cases)   OS Group (20 Cases)   Statistical Data
  --------------------- --------------------- --------------------- ---------------------
  Mean age (± SD) (y)   8.5±1.9               8±1.7                 *t*=0.73, *P*\>.05
  Sex                                                               χ^2^=0.01, *P*\>.05
      Male              5                     8                     
      Female            7                     12                    

The size of the spleen by ultrasonography ranged from 500 to 1000 g. The operative time ranged from 150 to 210 minutes in the LS group and from 110 to 180 minutes in the OS group.

There was 1 case (8%) of an intraoperative complication in the LS group. It was due to incomplete closure of the staples that resulted in incomplete hemostasis, which was controlled with a tissue sealing device. The conversion rate from LS to OS was 8% (1 case).

The mean amount of intraoperative blood loss was 60 mL in the LS group versus 110 mL in the OS group. Postoperative left lung lower lobe atelectasis developed in 2 cases in the OS group (10%) and 1 case in the LS group (8%), which was managed by chest physiotherapy.

Postoperatively, oral feeding was resumed within 6 to 8 hours in the LS group (mean, 7.5 hours) and 24 to 36 hours (mean, 30 hours) in the OS group. The mean hospital stay was 36 hours in the LS group versus 96 hours in the OS group.

Both groups of splenectomy patients were given intravenous acetaminophen/6h and a diclofenac sodium suppository/8h for the first 24 hours postoperatively as routine medications. Opioid injection was required in the first 24 hours in 2 cases in the LS group (17%) and all cases in the OS group (100%) (**[Table 2](#T2){ref-type="table"}**).

###### 

Variables Between Groups

  Variable                                             LS Group (12 Cases)   OS Group (20 Cases)   Statistical Data
  ---------------------------------------------------- --------------------- --------------------- -------------------------------------------------------
  Mean size of spleen (± SD) (g)                       800±157               850±185               *t*=1.9, *P*\>.05
  Mean operative time (± SD) (min)                     180±10                120±8                 *t*=9.7, *P*\<.001^[a](#TF2-1){ref-type="table-fn"}^
  Intraoperative complications                         1 case (8%)           0 cases (0%)          
  Mean intraoperative blood loss (± SD) (mL)           60±6                  110±9                 *t*=8.1, *P*\<.001^[a](#TF2-1){ref-type="table-fn"}^
  Postoperative complications                          1 case (8%)           2 cases (10%)         
  Mean time to start oral feeding (± SD) (h)           7.5±1                 30±2                  *t*=7.5, *P*\<.001^[a](#TF2-1){ref-type="table-fn"}^
  Use of opioids for pain management postoperatively   2 cases (17%)         20 cases (100%)       χ^2^=20.5, *P*\<.01^[a](#TF2-1){ref-type="table-fn"}^
  Mean length of hospital stay (± SD) (h)              36±7                  96±20                 *t*=8.04, *P*\<.05^[a](#TF2-1){ref-type="table-fn"}^

Statistically significant difference.

DISCUSSION
==========

The advantages of LS become less obvious in patients with large spleens. A spleen weight ≥1000 g has been associated with a longer operative time, higher conversion rate, and higher morbidity rate compared with LS for smaller spleens.^[@B7],[@B10]^ On the other hand, Targarona et al^[@B11],[@B12]^ and Grahn et al^[@B13]^ argued that their data on LS versus OS for massive splenomegaly favored the former approach, with a lower morbidity rate, reduced need for blood transfusion, and shorter postoperative hospital stay.

Currently, there is no consensus on the definition of massive splenomegaly. The lower weight limit applied in the adult literature to define massive splenomegaly has ranged between 500 g^[@B14]^ and 1000 g.^[@B15],[@B16]^ O\'Reilly^[@B17]^ defined splenomegaly as a spleen length of \>12 cm as estimated by 2 clinicians or spleen weight \>250 g in an excised spleen or on autopsy. In children, Zhu et al^[@B6]^ defined massive splenomegaly as a splenic margin below the umbilicus or anteriorly extending over the midline.

We used a splenic size of 500 g, by preoperative ultrasonography, as our lower limit to define massive splenomegaly in children in our study. All the patients in this study showed the same clinical characteristics described by Zhu et al^[@B6]^ for massive splenomegaly, but we preferred to rely on a more accurate definition for massive splenomegaly as described by Downey.^[@B8]^

In the first period of the study (June 2004 to June 2009), massive splenomegaly was performed with OS whereas LS was only performed for splenomegaly patients with a spleen weight \<500 g to build our experience.

The recent literature contains very few comparative studies between OS and LS for massive splenomegaly in children. Deng et al^[@B4]^ and Zhu et al^[@B6]^ recently published their retrospective studies of 57 children and 145 children, respectively, who required splenectomy for massive splenomegaly. Our study included 12 LS cases and 20 OS cases. There was no sex difference between the 2 groups. Age was nearly similar in both groups.

The difference in the size of the spleen in both groups was not statistically significant. The study of Deng et al,^[@B4]^ as well as our study, showed a statistically significantly longer operative time in the LS group, which is in concordance with the published literature in the adult population.^[@B7],[@B10],[@B16]^

Although there was only 1 case of an intraoperative complication in the LS group (8%), no intraoperative complications were encountered in the OS group. The complication rates for LS versus OS were 13.6% and 41.2%, respectively, in the study by Zhu et al.^[@B6]^ The single intraoperative complication encountered in our LS group was due to device failure and was not related to the size of the spleen itself. The device failure was possibly caused by increased thickness of the hilar vessels.

In concordance with our study, there was statistically significantly less intraoperative blood loss in the study of Deng et al^[@B4]^ in the LS group.

Deng et al^[@B4]^ reported a conversion rate of 13.33% in their study. Reports in the adult literature showed conversion rates ranging from 18.5% to 60% in cases of LS for massive splenectomy. There was 1 case of conversion (8%) in our study. (This case was occurred in the LS group.) The reason for conversion was severe adhesions around the spleen and the hilum (this was the third case of LS in our study); we believed that it was unsafe to proceed with the laparoscopy in this case.

There were statistically insignificantly fewer postoperative complications in the LS group versus the OS group (8% vs 10%), which concurs with the study by Deng et al.^[@B4]^ The postoperative time to resume oral feeding and postoperative hospital stay were statistically significantly less in the LS group. Deng et al and Owera et al^[@B5]^ showed the same results in their studies.

Patel et al^[@B7]^ reported, in their adult population, a 23% conversion rate, a 10-fold increase in morbidity rate, and prolongation of the hospital stay with the laparoscopic approach in 27 patients with massive splenomegaly.

The need for postoperative medications for pain management was statistically significantly less in the LS group than in the OS group in our study, concurring with the results of Owera et al.^[@B5]^ We used the word-graphic rating scale of Tesler et al^[@B9]^ for evaluation of pain severity; patients with a rating for large pain or worst possible pain on the scale were given opioid analgesics.

In an elegant study in adults, Grahn et al^[@B13]^ concluded that "the laparoscopic approach should be considered for patients requiring elective splenectomy regardless of spleen size," and we support this statement. Our study emphasizes that all cases of elective splenectomy for hematologic disorders in children could be better managed laparoscopically.

CONCLUSION
==========

LS for massive splenomegaly in the pediatric age group is safe and feasible to perform under some precautions to prevent conversion to the open technique. Although there was a significantly greater operative time in the LS group, LS was associated with statistically significantly less pain, less intraoperative blood loss, better recovery, shorter postoperative hospital stay, and better cosmesis.

LS for pediatric hematologic disorders should be the gold-standard approach regardless of the size of the spleen.
